Cyclacel Pharmaceuticals, Inc. (BGMS) at a glance

Cyclacel Pharmaceuticals, Inc. (BGMS) is a micro-cap Healthcare company. It trades at $0.61, with a P/E of 0.2, a -204.2% profit margin and revenue growth of 16.8%. It does not pay a dividend. Vestovix scores it 64/100 overall. Its strongest dimension is Value (89/100) and its weakest is Momentum (12/100).

Price

$0.61

Market cap

$4.3M

P/E ratio

0.2

Dividend yield

None

Beta

n/a

52-week range

$0.60 to $19.87